Jon R. Levine - 27 Apr 2023 Form 4 Insider Report for MARIMED INC. (MRMD)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Jon R. Levine
Issuer symbol: MRMD
Transactions as of: 27 Apr 2023
Net transactions value: -$18,611
Form type: 4
Filing time: 01 May 2023, 19:59:39 UTC
Previous filing: 14 Mar 2023
Next filing: 30 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRMD	Common stock	Options Exercise		+138,889	+0.69%		20,150,976	27 Apr 2023	Direct	F1
transaction	MRMD	Common stock	Sale	$18,611	-49,393	-0.25%	$0.3768	20,101,583	28 Apr 2023	Direct	F2
holding	MRMD	Common stock						6,684,640	27 Apr 2023	By the Jon Levine Family Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRMD	Restricted Stock Units (RSU)	Options Exercise	$0	-138,889	-17%	$0.000000	694,444	27 Apr 2023	Common Stock, par value $.001 per share	138,889		Direct	F1, F4
holding	MRMD	Restricted Stock Units (RSU)						140,000	27 Apr 2023	Common Stock, par value $.001 per share	140,000		Direct	F1, F5
holding	MRMD	Option to buy common stock						5,000,000	27 Apr 2023	Common Stock, par value $.001 per share	5,000,000	$0.8980	Direct	F6
holding	MRMD	Option to buy common stock						5,000,000	27 Apr 2023	Common Stock, par value $.001 per share	5,000,000	$0.8800	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	RSUs convert to common stock on a one-for-one basis.
F2	Reflects shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the RSUs.
F3	The shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4	The RSUs vest over a three year period in equal one-sixth installments every sis months following the October 27, 2022 grant date, in accordance with the terms of an award agreement, between the Issuer and the Reporting Person.
F5	The RSUs vest over a three year period of which 46,667 RSUs will vest on March 7, 2024 and thereafter, 23,333 RSUs will vest every succeeding six (6) months through March 7, 2026, on each of September 7 and March 7, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
F6	Immediately